Logo image of DYAI

DYADIC INTERNATIONAL INC (DYAI) Stock Fundamental Analysis

USA - NASDAQ:DYAI - US26745T1016 - Common Stock

0.9124 USD
+0.01 (+0.82%)
Last: 11/14/2025, 8:00:01 PM
Fundamental Rating

2

Taking everything into account, DYAI scores 2 out of 10 in our fundamental rating. DYAI was compared to 531 industry peers in the Biotechnology industry. DYAI may be in some trouble as it scores bad on both profitability and health. DYAI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DYAI has reported negative net income.
In the past year DYAI has reported a negative cash flow from operations.
In the past 5 years DYAI always reported negative net income.
In the past 5 years DYAI always reported negative operating cash flow.
DYAI Yearly Net Income VS EBIT VS OCF VS FCFDYAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a Return On Assets value of -68.51%, DYAI is not doing good in the industry: 61.02% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -68.51%
ROE N/A
ROIC N/A
ROA(3y)-70.74%
ROA(5y)-60.92%
ROE(3y)-146.19%
ROE(5y)-108.49%
ROIC(3y)N/A
ROIC(5y)N/A
DYAI Yearly ROA, ROE, ROICDYAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

DYAI's Gross Margin of 59.86% is fine compared to the rest of the industry. DYAI outperforms 77.97% of its industry peers.
DYAI's Gross Margin has improved in the last couple of years.
DYAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y50.87%
GM growth 5Y38.12%
DYAI Yearly Profit, Operating, Gross MarginsDYAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, DYAI has more shares outstanding
The number of shares outstanding for DYAI has been increased compared to 5 years ago.
Compared to 1 year ago, DYAI has a worse debt to assets ratio.
DYAI Yearly Shares OutstandingDYAI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
DYAI Yearly Total Debt VS Total AssetsDYAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -14.32, we must say that DYAI is in the distress zone and has some risk of bankruptcy.
DYAI's Altman-Z score of -14.32 is on the low side compared to the rest of the industry. DYAI is outperformed by 78.53% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.32
ROIC/WACCN/A
WACCN/A
DYAI Yearly LT Debt VS Equity VS FCFDYAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.02 indicates that DYAI has no problem at all paying its short term obligations.
The Current ratio of DYAI (2.02) is worse than 75.14% of its industry peers.
DYAI has a Quick Ratio of 2.02. This indicates that DYAI is financially healthy and has no problem in meeting its short term obligations.
DYAI has a worse Quick ratio (2.02) than 73.45% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 2.02
DYAI Yearly Current Assets VS Current LiabilitesDYAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for DYAI have decreased by -4.35% in the last year.
The Revenue has grown by 20.58% in the past year. This is a very strong growth!
The Revenue has been growing by 15.78% on average over the past years. This is quite good.
EPS 1Y (TTM)-4.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)20.58%
Revenue growth 3Y13.35%
Revenue growth 5Y15.78%
Sales Q2Q%-41.24%

3.2 Future

The Earnings Per Share is expected to grow by 8.75% on average over the next years. This is quite good.
The Revenue is expected to grow by 58.83% on average over the next years. This is a very strong growth
EPS Next Y1.83%
EPS Next 2Y21.37%
EPS Next 3Y8.75%
EPS Next 5YN/A
Revenue Next Year-5.81%
Revenue Next 2Y32.95%
Revenue Next 3Y25%
Revenue Next 5Y58.83%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DYAI Yearly Revenue VS EstimatesDYAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20M 40M 60M 80M
DYAI Yearly EPS VS EstimatesDYAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DYAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DYAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DYAI Price Earnings VS Forward Price EarningsDYAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DYAI Per share dataDYAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.37%
EPS Next 3Y8.75%

More info and screens

0

5. Dividend

5.1 Amount

DYAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DYADIC INTERNATIONAL INC

NASDAQ:DYAI (11/14/2025, 8:00:01 PM)

0.9124

+0.01 (+0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-24 2026-03-24/amc
Inst Owners13.88%
Inst Owner Change9.54%
Ins Owners14.79%
Ins Owner Change0.51%
Market Cap33.02M
Revenue(TTM)3.50M
Net Income(TTM)-5.58M
Analysts82.5
Price Target5.78 (533.49%)
Short Float %0.37%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-37.04%
PT rev (3m)-37.04%
EPS NQ rev (1m)-44.43%
EPS NQ rev (3m)-44.43%
EPS NY rev (1m)-10%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)-26.67%
Revenue NQ rev (3m)-26.67%
Revenue NY rev (1m)-11.96%
Revenue NY rev (3m)-3.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.99
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.11
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -68.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.86%
FCFM N/A
ROA(3y)-70.74%
ROA(5y)-60.92%
ROE(3y)-146.19%
ROE(5y)-108.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y50.87%
GM growth 5Y38.12%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 2.02
Altman-Z -14.32
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next Y1.83%
EPS Next 2Y21.37%
EPS Next 3Y8.75%
EPS Next 5YN/A
Revenue 1Y (TTM)20.58%
Revenue growth 3Y13.35%
Revenue growth 5Y15.78%
Sales Q2Q%-41.24%
Revenue Next Year-5.81%
Revenue Next 2Y32.95%
Revenue Next 3Y25%
Revenue Next 5Y58.83%
EBIT growth 1Y32.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.16%
OCF growth 3YN/A
OCF growth 5YN/A

DYADIC INTERNATIONAL INC / DYAI FAQ

What is the ChartMill fundamental rating of DYADIC INTERNATIONAL INC (DYAI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DYAI.


What is the valuation status for DYAI stock?

ChartMill assigns a valuation rating of 0 / 10 to DYADIC INTERNATIONAL INC (DYAI). This can be considered as Overvalued.


What is the profitability of DYAI stock?

DYADIC INTERNATIONAL INC (DYAI) has a profitability rating of 1 / 10.


How financially healthy is DYADIC INTERNATIONAL INC?

The financial health rating of DYADIC INTERNATIONAL INC (DYAI) is 2 / 10.